BACKGROUND: Cluster randomized trials, which randomize groups of patients rather than individuals, are commonly used to evaluate healthcare interventions such as training programmes targeted at health professionals. This article reports the dangers of randomizing entire primary care practices when participants cannot be identified before randomization, as shown by a UK national trial. METHOD: The UK BEAM trial, a national cluster randomized 3 x 2 x 2 factorial trial, was designed to evaluate three treatments for back pain in primary care: "active management"; randomized by practice; and spinal manipulation and exercise classes, both randomized by individual. RESULTS:Two hundred and thirty-one participants were recruited in the feasibility study, 165 (141% of expected recruitment) from active (management) practices but only 66 (54% of expected recruitment) from traditional (management) practices. The participants in active practices were significantly different from those in traditional practices, notably in suffering from milder back pain. CONCLUSIONS: The feasibility study highlighted the dangers of randomizing clusters when individuals cannot be identified beforehand. Different numbers and types of participants were recruited in the two types of cluster. This differential recruitment led us to change the main trial design by abandoning practice level randomization. Instead all practices were trained in active management to maximize recruitment. Ideally cluster randomized trials should identify patients beforehand, to minimize the chance of selection bias. If this is not possible, patient recruitment should be independent in both intervention and control clusters. Pilot studies are especially important for cluster randomized trials, to identify unforeseen problems.
RCT Entities:
BACKGROUND: Cluster randomized trials, which randomize groups of patients rather than individuals, are commonly used to evaluate healthcare interventions such as training programmes targeted at health professionals. This article reports the dangers of randomizing entire primary care practices when participants cannot be identified before randomization, as shown by a UK national trial. METHOD: The UK BEAM trial, a national cluster randomized 3 x 2 x 2 factorial trial, was designed to evaluate three treatments for back pain in primary care: "active management"; randomized by practice; and spinal manipulation and exercise classes, both randomized by individual. RESULTS: Two hundred and thirty-one participants were recruited in the feasibility study, 165 (141% of expected recruitment) from active (management) practices but only 66 (54% of expected recruitment) from traditional (management) practices. The participants in active practices were significantly different from those in traditional practices, notably in suffering from milder back pain. CONCLUSIONS: The feasibility study highlighted the dangers of randomizing clusters when individuals cannot be identified beforehand. Different numbers and types of participants were recruited in the two types of cluster. This differential recruitment led us to change the main trial design by abandoning practice level randomization. Instead all practices were trained in active management to maximize recruitment. Ideally cluster randomized trials should identify patients beforehand, to minimize the chance of selection bias. If this is not possible, patient recruitment should be independent in both intervention and control clusters. Pilot studies are especially important for cluster randomized trials, to identify unforeseen problems.
Authors: Elizabeth Dormandy; Fred Kavalier; Jane Logan; Hilary Harris; Nola Ishmael; Theresa M Marteau Journal: Br J Gen Pract Date: 2008-11 Impact factor: 5.386
Authors: Anna D T Muntingh; Christina M van der Feltz-Cornelis; Harm W J van Marwijk; Philip Spinhoven; Willem J J Assendelft; Margot W M de Waal; Leona Hakkaart-van Roijen; Herman J Adèr; Anton J L M van Balkom Journal: BMC Health Serv Res Date: 2009-09-08 Impact factor: 2.655
Authors: Joanne E McKenzie; Denise A O'Connor; Matthew J Page; Duncan S Mortimer; Simon D French; Bruce F Walker; Jennifer L Keating; Jeremy M Grimshaw; Susan Michie; Jill J Francis; Sally E Green Journal: Implement Sci Date: 2010-11-10 Impact factor: 7.327
Authors: Matthew J Page; Simon D French; Joanne E McKenzie; Denise A O'Connor; Sally E Green Journal: BMC Med Res Methodol Date: 2011-03-31 Impact factor: 4.615
Authors: Peter A Coventry; Karina Lovell; Chris Dickens; Peter Bower; Carolyn Chew-Graham; Andrea Cherrington; Charlotte Garrett; Chris J Gibbons; Clare Baguley; Kate Roughley; Isabel Adeyemi; Chris Keyworth; Waquas Waheed; Mark Hann; Linda Davies; Farheen Jeeva; Chris Roberts; Sarah Knowles; Linda Gask Journal: Trials Date: 2012-08-20 Impact factor: 2.279